Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Children's Hospital Los Angeles
Children's Oncology Group
Children's Oncology Group
St. Anna Kinderkrebsforschung
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Samsung Medical Center
St. Jude Children's Research Hospital
Children's Oncology Group
Samsung Medical Center
NYU Langone Health
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Tehran University of Medical Sciences
National Institutes of Health Clinical Center (CC)
New Approaches to Neuroblastoma Therapy Consortium
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital